
Navigating Obesity Treatment: Bariatric Surgery, GLP-1 Medications, or Both?
Author: nwwls.com Obesity remains a significant public health challenge, affecting over 42% of adults in the United States. The rise of glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide and tirzepatide, has introduced new avenues for weight management. Concurrently, bariatric...
Read More